<DOC>
	<DOCNO>NCT02081729</DOCNO>
	<brief_summary>VZV one important opportunistic infection transplant recipients.Until , laboratory method stratify risk VZV reactivation solid organ transplantation . Theoretically , VZV-specific cell-mediate immune response solid organ transplantation categorize patient high low risk VZV development solid organ transplantation . The investigator thus evaluate usefulness VZV-specific ELISPOT assay kidney transplant candidate predict development VZV infection kidney transplantation .</brief_summary>
	<brief_title>Assessment VZV-specific ELISPOT Assay Predicting VZV Infection Kidney Transplant Recipients ( AVE-KT )</brief_title>
	<detailed_description>We develop VZV-specific ELISPOT assay , perform assay transplantation . We evaluate whether assay predict zoster reactivation transplantation .</detailed_description>
	<criteria>age 16 year agree write informed consent WBC count 2000/uL exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>